Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Sales | 46,099,000 | 50,135,000 | 49,436,000 | 50,387,000 | 53,634,000 |
Cost of Goods | 14,510,000 | 17,175,000 | 17,520,000 | 17,404,000 | 17,345,000 |
Gross Profit | 31,589,000 | 32,960,000 | 31,916,000 | 32,983,000 | 36,289,000 |
Operating Expenses | 23,186,000 | 24,331,000 | 23,648,000 | 24,006,000 | 25,200,000 |
Operating Income | 8,403,000 | 8,629,000 | 8,268,000 | 8,977,000 | 11,089,000 |
Interest Expense | 932,000 | 777,000 | 707,000 | 655,000 | 704,000 |
Other Income | 6,624,000 | 1,147,000 | 256,000 | -188,000 | 1,887,000 |
Pre-tax Income | 14,095,000 | 8,999,000 | 7,817,000 | 8,134,000 | 12,272,000 |
Income Tax | 1,295,000 | 1,296,000 | 1,119,000 | 1,106,000 | 1,545,000 |
Net Income Continuous | 12,800,000 | 7,703,000 | 6,698,000 | 7,028,000 | 10,727,000 |
Net Income Discontinuous | -186,000 | N/A | N/A | 10,766,000 | -447,000 |
Minority Interests | 3,000 | 0 | -14,000 | 11,000 | 70,000 |
Net Income | $12,611,000 | $7,703,000 | $6,712,000 | $17,783,000 | $10,210,000 |
EPS Basic Total Ops | 5.44 | 3.28 | 2.82 | 7.40 | 4.21 |
EPS Basic Continuous Ops | 5.52 | 3.28 | 2.82 | 2.92 | 4.39 |
EPS Basic Discontinuous Ops | -0.08 | N/A | N/A | 4.48 | -0.18 |
EPS Diluted Total Ops | 5.38 | 3.25 | 2.80 | 7.29 | 4.13 |
EPS Diluted Continuous Ops | 5.46 | 3.25 | 2.82 | 2.88 | 4.31 |
EPS Diluted Discontinuous Ops | -0.08 | N/A | N/A | 4.41 | -0.18 |
EPS Diluted Before Non-Recurring Items | 5.09 | N/A | N/A | N/A | N/A |
EBITDA(a) | $13,620,000 | $14,961,000 | $14,443,000 | $8,977,000 | $11,089,000 |